UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000007237 |
|---|---|
| Receipt number | R000008529 |
| Scientific Title | Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG) AML-D11:A Phase II Study to evaluate the feasibility and utility of minimal residual disease (MRD) for childhood acute myeloid leukemia with Down syndrome |
| Date of disclosure of the study information | 2012/03/01 |
| Last modified on | 2021/09/06 17:35:57 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2012/02/07 09:04:10 | ||
| 2 | Update | 2014/04/24 14:19:07 | Recruitment status |
|
| 3 | Update | 2014/04/24 14:22:29 | Address Last name of contact person Last name of contact person Organization Organization Division name Division name Address Address TEL |
|
| 4 | Update | 2015/08/07 10:14:44 | Recruitment status Last follow-up date |
|
| 5 | Update | 2021/02/13 18:37:16 | Stratification Dynamic allocation Institution consideration Blocking Concealment |
|
| 6 | Update | 2021/02/13 18:48:17 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Address Address Last name of contact person Last name of contact person Zip code Address Address Name of primary person or sponsor Organization Category of Funding Organization Organization Organization Address Address Tel |
|
| 7 | Update | 2021/09/06 16:43:47 | Recruitment status Date of IRB Date trial data considered complete |
|
| 8 | Update | 2021/09/06 17:35:57 | URL releasing protocol Publication of results URL related to results and publications Number of participants that the trial has enrolled Results Results Results date posted Date of the first journal publication of results Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
